ArticleNeuroscience letters2026

Xylazine reduces methamphetamine-induced hyperlocomotion in rats through κ-opioid and α2-adrenoceptor mechanisms.

Sonita Wiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.